Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma
This study is currently recruiting participants.
Verified April 2013 by City of Hope Medical Center
Study NCT01476839
Information provided by City of Hope Medical Center
First Received on November 18, 2011.
Last Updated on April 18, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
